KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q2 2021?

108 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 51,679,622
Total 13F shares: 24,320,398
Share change: +620,320
Total reported value: $582,722,986
Put/Call ratio: 154%
Price per share: $23.96
Number of holders: 108
Value change: +$12,095,008
Number of buys: 54
Number of sells: 63

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Vivo Capital, LLC	13F	Company	3.6%	1,863,296	$47,868,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	3%	1,559,488	$40,062,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.9%	1,509,025	$38,767,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.7%	1,373,000	$35,272,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	2.6%	1,347,970	$34,630,000	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	2.5%	1,287,661	$33,080,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.2%	1,133,772	$29,117,000	—	31 Mar 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2%	1,020,005	$26,204,000	—	31 Mar 2021	13F
Polar Capital Holdings Plc	13F	Company	1.9%	1,007,055	$25,871,000	—	31 Mar 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	959,892	$24,660,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.8%	929,481	$23,878,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.6%	805,000	$20,680,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	1.5%	750,000	$19,268,000	—	31 Mar 2021	13F
Nicholas Investment Partners, LP	13F	Company	1.1%	594,130	$15,263,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.1%	591,472	$15,195,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	1.1%	565,729	$14,534,000	—	31 Mar 2021	13F
Stonepine Capital Management, LLC	13F	Company	0.82%	422,310	$10,849,000	—	31 Mar 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.81%	416,212	$10,692,000	—	31 Mar 2021	13F
EMERALD ADVISERS, LLC	13F	Company	0.77%	397,283	$10,206,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.68%	350,000	$8,992,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.63%	327,267	$8,407,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.57%	296,965	$7,629,000	—	31 Mar 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.5%	258,880	$6,651,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.44%	228,670	$5,875,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.44%	228,625	$5,873,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.43%	224,059	$5,756,000	—	31 Mar 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.42%	218,163	$5,605,000	—	31 Mar 2021	13F
Commodore Capital LP	13F	Company	0.41%	214,467	$5,510,000	—	31 Mar 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.42%	214,533	$5,486,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.3%	153,428	$3,942,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.25%	128,130	$3,292,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	0.23%	120,000	$3,083,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.21%	110,504	$2,839,000	—	31 Mar 2021	13F
Informed Momentum Co LLC	13F	Company	0.21%	106,777	$2,743,000	—	31 Mar 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.19%	100,000	$2,569,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.19%	98,178	$2,523,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.16%	80,673	$2,072,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.13%	66,020	$1,696,000	—	31 Mar 2021	13F
Global IMC LLC	13F	Company	0.13%	64,603	$1,660,000	—	31 Mar 2021	13F
DAFNA Capital Management LLC	13F	Company	0.11%	58,600	$1,505,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	54,599	$1,403,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.16%	83,090	$1,297,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.1%	50,244	$1,291,000	—	31 Mar 2021	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	50,000	$1,285,000	—	31 Mar 2021	13F
Tekla Capital Management LLC	13F	Company	0.1%	50,000	$1,285,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.09%	47,681	$1,225,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.09%	47,116	$1,210,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	46,897	$1,205,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	45,411	$1,167,000	—	31 Mar 2021	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.08%	40,567	$1,042,000	—	31 Mar 2021	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q2 2021

As of 30 Jun 2021, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,320,398 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, BlackRock Inc., STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and FMR LLC. This page lists 108 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

115

Q2 2021 holders

108

Holder diff

-7

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.